To enroll in Self-Instruction, visit the Products Page. If you have any questions, or if you are unsure of your enrollment status, please call the Manager, Examinations and Self-Instruction, toll-free at 888.243.3368, ext. 4336.

Participants must answer at least 12 of 15 questions correctly (80%) to earn CE credit.

Note: Exercise 994 is a special edition of the Self-Instruction Exercises and is only available to those members/nonmembers who attended the 2017 Scientific Session in Las Vegas. If you submit exercise 994 but did not attend the Scientific Session, the exercise will not be processed and your payment will be returned.

AGD - Self-Instruction Exercise No. 413 - Special Patient Care
Dental management of patients with inherited bleeding disorders: a multidisciplinary approach

Self-Instruction Exercise No. 413
Member Information
Required for AGD members
Required for non-members
Are you an AGD member?
Yes    No
If Yes, please enter your AGD Number:
Full Name (First & Last):
Address:
Address 2:
City:
State/Province:
ZIP/Postal Code:
Country:
E-mail:
Promotional Code


Payment Information
I am currently enrolled in the Self-Instruction program. (If you are unsure of your enrollment status, please call 888.243.3368, ext. 4336.)
Enroll me for Self-Instruction so that I can submit this exercise. My credit card information is entered below. I understand that my card will be charged $30 if I am an AGD member and $50 if I am a non-member.
 
Card Type  
Visa          MasterCard    American Express   
Card Number  
Expiration Date    


Exercise No. 413
Subject Code: 750
Special Patient Care

The 15 questions for this exercise are based on the article Dental management of patients with inherited bleeding disorders: a multidisciplinary approach on pages 56-60. This exercise was developed by Anthony S. Carroccia, DDS, MAGD, ABGD, in association with the General Dentistry Self-Instruction committee.

Reading the article and successfully completing this exercise will enable you to:

  • understand the nature of hemophilia A and von Willebrand disease;
  • recognize variant types of medical interventions; and
  • identify some measures that must be taken to treat these dental patients.

Answers for this exercise must be received by October 31, 2018.

  1. All of the following are reasons for bleeding disorders except one. Which is the exception?

    A. anticoagulant medications
    B. blood type
    C. inherited defect
    D. medical condition

  2. All of the following may affect the severity of a bleeding episode except one. Which is the exception?

    A. deficiency of any clotting factor
    B. defect in platelets
    C. deficiency of hemoglobin
    D. defect in the vascular wall

  3. Patients with Marfan syndrome, Osler-Weber-Rendu syndrome, and Ehlers-Danlos syndrome often have severe bleeding after extractions. They must receive dental treatment outside of a primary care setting.

    A. Both statements are true.
    B. The first statement is true; the second is false.
    C. The first statement is false; the second is true.
    D. Both statements are false.

  4. Von Willebrand disease affects ___% of the population.

    A. 1
    B. 3
    C. 5
    D. 10

  5. Von Willebrand factor acts as a carrier for factor ____.

    A. VI
    B. VII
    C. VIII
    D. IX

  6. Desmopressin is the typical treatment for patients with a severe form of von Willebrand disease. Desmopressin is needed as a replacement to a factor concentrate rich in von Willebrand factor.

    A. Both statements are true.
    B. The first statement is true; the second is false.
    C. The first statement is false; the second is true.
    D. Both statements are false.

  7. Hemophilia A is a genetically __________ -linked trait.

    A. dominant X
    B. dominant Y
    C. recessive X
    D. recessive Y

  8. Which drug may be used safely in patients with bleeding disorders after dental treatment?

    A. aspirin
    B. ibuprofen
    C. naproxen
    D. paracetamol

  9. Hemophiliacs who have not received hematologic prophylactic coverage can develop a hematoma after an inferior alveolar injection __% of the time.

    A. 80
    B. 60
    C. 40
    D. 20

  10. Desmopressin administered intravenously may have all of the following cardiovascular side effects except one. Which is the exception?

    A. elevated heart rate
    B. headache
    C. hypertension
    D. hypotension

  11. Recombinant factor should not be given to a patient with moderate to severe hemophilia A. It is recommended to treat a dental patient with hemophilia 30-60 minutes after the administration of factor concentrate.

    A. Both statements are true.
    B. The first statement is true; the second is false.
    C. The first statement is false; the second is true.
    D. Both statements are false.

  12. Tranexamic acid alone reduces the probability of postoperative bleeding to ____% when used as an oral mouthwash.

    A. 75
    B. 50
    C. 5.4
    D. 3.6

  13. Use of tranexamic acid mouthwash should be started ___ hours before a dental procedure.

    A. 2
    B. 4
    C. 7
    D. 10

  14. Hemophilia A types are based on the percentage of factor _____ in the plasma.

    A. IX
    B. VIII
    C. VII
    D. VI

  15. In moderate hemophilia A, the plasma level of the affected factor is ________%.

    A. less than 1
    B. 2-5
    C. 6-10
    D. 10-15


Evaluation

Please respond to the statements below, using the following scale:
1 Poor; 2 Below average; 3 Average; 4 Above average; 5 Excellent

Practicality of the content 1 2 3 4 5
Benefit to your clinical practice 1 2 3 4 5
Quality of illustrations 1 2 3 4 5
Clarity of objectives 1 2 3 4 5
Clarity of exercise questions 1 2 3 4 5
Relevance of exercise questions 1 2 3 4 5
 
Did this exercise achieve its objectives? Yes No
Did this article present new information? Yes No
How much time did it take you to complete this exercise? mins


Cancel